spironolactone has been researched along with phenylephrine in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (18.18) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Brody, MJ; Janiak, P | 1 |
| Wang, W | 1 |
| Cobbs, S; Jiang, G; Klein, JD; O'Neill, WC | 1 |
| GREENOUGH, WB; JANUSZEWICZ, V; LARAGH, JH; SONNENBLICK, EH | 1 |
| Delpiano, AM; Hitschfeld, C; Lavandero, S; Lobos, L; Marusic, ET; Michea, L | 1 |
| Fujita, M; Hasegawa, K; Kawamura, T; Kita, T; Morimoto, T; Shimatsu, A; Sunagawa, Y; Takaya, T; Wada, H; Yoshida, Y | 1 |
| Adamová, Z; Adler, GK; Khalil, RA; Kumar, A; Pojoga, LH; Romero, JR; Stennett, AK; Williams, GH | 1 |
| Çaylak, B; Erdem, ŞR; Köse, MG; Peșkircioğlu, ÇL | 1 |
| Carreño, JE; Contreras, F; Irarrazabal, CE; Marusic, E; Montellano, FA; Sandoval, M; Schalper, KA; Veloso, S; Verdugo, FJ; Villanueva, S | 1 |
11 other study(ies) available for spironolactone and phenylephrine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Central interactions between aldosterone and vasopressin on cardiovascular system.
Topics: Aldosterone; Angiotensin II; Animals; Arginine Vasopressin; Blood Pressure; Carbachol; Cardiovascular System; Drug Interactions; Heart Rate; Male; Phenylephrine; Rats; Rats, Inbred Strains; Receptors, Mineralocorticoid; Receptors, Steroid; Spironolactone; Vasopressins | 1988 |
Chronic administration of aldosterone depresses baroreceptor reflex function in the dog.
Topics: Aldosterone; Animals; Baroreflex; Blood Pressure; Catheters, Indwelling; Dogs; Female; Heart Rate; Infusions, Parenteral; Male; Nitroglycerin; Ouabain; Phenylephrine; Pressoreceptors; Reference Values; Regression Analysis; Spironolactone; Time Factors | 1994 |
Aldosterone regulates the Na-K-2Cl cotransporter in vascular smooth muscle.
Topics: Adrenalectomy; Aldosterone; Animals; Aorta; Bumetanide; Dose-Response Relationship, Drug; In Vitro Techniques; Male; Mineralocorticoid Receptor Antagonists; Muscle, Smooth, Vascular; Phenylephrine; Rats; Rats, Sprague-Dawley; RNA, Messenger; Rubidium Radioisotopes; Sodium-Potassium-Chloride Symporters; Spironolactone; Time Factors; Vasoconstrictor Agents | 2003 |
Correction of hyperaldosteronism and of massive fluid retention of unknown cause by sympathomimetic agents.
Topics: Amphetamine; Edema; Heart Failure; Humans; Hyperaldosteronism; Hypotension; Hypotension, Orthostatic; Phenylephrine; Spironolactone; Sympathomimetics | 1962 |
Eplerenone blocks nongenomic effects of aldosterone on the Na+/H+ exchanger, intracellular Ca2+ levels, and vasoconstriction in mesenteric resistance vessels.
Topics: Aldosterone; Androstadienes; Animals; Blotting, Western; Calcium; Chromones; Enzyme Inhibitors; Eplerenone; Flavonoids; Hydrogen-Ion Concentration; Indoles; Male; Maleimides; Mesenteric Arteries; Mineralocorticoid Receptor Antagonists; Morpholines; p38 Mitogen-Activated Protein Kinases; Phenylephrine; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Kinase C; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Sodium-Hydrogen Exchanger 1; Sodium-Hydrogen Exchangers; Spironolactone; Time Factors; Vasoconstriction; Wortmannin | 2005 |
Aldosterone signaling associates with p300/GATA4 transcriptional pathway during the hypertrophic response of cardiomyocytes.
Topics: Aldosterone; Animals; Atrial Natriuretic Factor; Chlorocebus aethiops; COS Cells; Disease Models, Animal; E1A-Associated p300 Protein; GATA4 Transcription Factor; Hypertrophy; Mice; Myocytes, Cardiac; NIH 3T3 Cells; Phenylephrine; Rats; Receptors, Mineralocorticoid; Signal Transduction; Spironolactone; Transfection | 2010 |
Sensitivity of NOS-dependent vascular relaxation pathway to mineralocorticoid receptor blockade in caveolin-1-deficient mice.
Topics: Acetylcholine; Aldosterone; Animals; Caveolin 1; Eplerenone; Male; Mice; Mice, Knockout; Mineralocorticoid Receptor Antagonists; Models, Animal; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Phenylephrine; Receptors, Mineralocorticoid; Signal Transduction; Sodium Chloride, Dietary; Spironolactone; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2010 |
Effects of angiogenesis inhibition by spironolactone on isolated vas deferens contractility in an experimental varicocele model in rats.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-1 Receptor Antagonists; Angiogenesis Inhibitors; Animals; In Vitro Techniques; Isometric Contraction; Ketanserin; Male; Microvessels; Muscle, Smooth; Neovascularization, Physiologic; Phenylephrine; Prazosin; Rats; Rats, Wistar; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Spermatogenesis; Spironolactone; Statistics, Nonparametric; Testis; Varicocele; Vas Deferens | 2012 |
Spironolactone inhibits the activity of the Na+/H+ exchanger in the aorta of mineralocorticoid-induced hypertensive rats.
Topics: Animals; Aorta; Blood Pressure; Desoxycorticosterone; Hypertension; Male; Mineralocorticoids; Phenylephrine; Rats, Sprague-Dawley; Sodium-Hydrogen Exchanger 1; Sodium-Hydrogen Exchangers; Spironolactone; Staining and Labeling; Vasoconstriction | 2015 |